Overview
NovoLog 70/30 is a prescription drug approved by the Food and Drug Administration (FDA) to treat diabetes. NovoLog 70/30 is also referred to by its drug name, 70% insulin aspart protamine and 30% insulin aspart (rDNA origin).
NovoLog 70/30 is a combination of short-acting and intermediate-acting human insulin analogs. An insulin analog is a synthetic substance very similar to human insulin. Insulin analogs are designed to affect the body more predictably than human insulin does.
How do I take it?
Prescribing information states that NovoLog 70/30 should be administered via a subcutaneous injection. Your doctor will explain when and where you should inject NovoLog 70/30 and how to measure your dosage. NovoLog 70/30 is usually prescribed to be taken twice daily.... read more
We never share your personal information with anyone.